Cargando…

Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing

Detalles Bibliográficos
Autores principales:	Angona, A, Fernández-Rodríguez, C, Alvarez-Larrán, A, Camacho, L, Longarón, R, Torres, E, Pairet, S, Besses, C, Bellosillo, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022184/ https://www.ncbi.nlm.nih.gov/pubmed/27564461 http://dx.doi.org/10.1038/bcj.2016.75

Ejemplares similares

miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia
por: Navarro, A, et al.
Publicado: (2016)

Headache in essential thrombocythaemia
por: Frewin, R, et al.
Publicado: (2012)

Unrecognized pseudohyperkalaemia in essential thrombocythaemia
por: Mannu, Gurdeep Singh, et al.
Publicado: (2011)

Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2022)

Efficacy and Safety of Cytoreductive Therapies in Patients with Essential Thrombocythaemia Aged >80 Years: An Interim Analysis of the EXELS Study
por: Kiladjian, Jean-Jacques, et al.
Publicado: (2012)

Herbaspirillum huttiense pneumonia in a patient with essential thrombocythaemia
por: Abreu-Di Berardino, Melanie, et al.
Publicado: (2019)

Can platelet count be controlled with ticagrelor in patients with essential thrombocythaemia? A case series
por: Yılmaz, Samet, et al.
Publicado: (2023)

Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib
por: March-Rodriguez, Álvaro, et al.
Publicado: (2019)

Nonfamilial, MPL S505N-Mutated Essential Thrombocythaemia
por: Morrell, Ruth, et al.
Publicado: (2013)

Can post-splenectomy thrombocytosis mask essential thrombocythaemia?
por: Langabeer, Stephen E.
Publicado: (2020)

Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia
por: Gotic, Mirjana, et al.
Publicado: (2020)

Essential Thrombocythaemia with Concomitant Waldenström Macroglobulinaemia: Case Report and Literature Review
por: Lu, Nina, et al.
Publicado: (2020)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
por: Mathur, Abhinav, et al.
Publicado: (2022)

Nadroparine-induced skin necrosis on a patient with essential thrombocythaemia: a case report
por: Pramateftakis, Manousos-Georgios, et al.
Publicado: (2009)

Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literature
por: Arampatzis, Spyridon, et al.
Publicado: (2010)

Percutaneous coronary intervention in a patient with heparin resistance due to essential thrombocythaemia: a case report
por: Okabe, Toshitaka, et al.
Publicado: (2021)

Catastrophic antiphospholipid syndrome complicated with essential thrombocythaemia after COVID-19 vaccination: in search of the underlying mechanism
por: Jinno, Sadao, et al.
Publicado: (2021)

Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels
por: Lewandowski, Krzysztof, et al.
Publicado: (2022)

CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythaemia
por: Bennett, Cavan, et al.
Publicado: (2022)

Novel lysine‐specific histone demethylase 1 inhibitor in acute myeloid leukaemia transformed from essential thrombocythaemia
por: Hodges, Samantha, et al.
Publicado: (2021)

P997: PROTEOMIC ANALYSIS ON PLATELETS OF ESSENTIAL THROMBOCYTHEMIA PATIENTS UNDERSCORES THE ROLE OF MITOCHONDRIA IN JAK2 V617F PLATELET REACTIVITY AND FUNCTION
por: Guerrero-Carreño, X., et al.
Publicado: (2022)

Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera
por: Tiong, I S, et al.
Publicado: (2016)

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
por: Garcia-Gisbert, Nieves, et al.
Publicado: (2022)

Prostaglandin cyclooxygenase products but not thromboxane A(2) are involved in the pathogenesis of ewthromelalgia in thrombocythaemia
por: Michiels, J. J., et al.
Publicado: (1993)

Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2021)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
por: Okikiolu, Jumoke, et al.
Publicado: (2022)

Rescue balloon pulmonary angioplasty for worsening chronic thromboembolic pulmonary hypertension with essential thrombocythaemia and the JAK2-V617F mutation: a case report
por: Tamura, Hiroto, et al.
Publicado: (2023)

Molecular characterisation of cell line models for triple-negative breast cancers
por: Grigoriadis, Anita, et al.
Publicado: (2012)

Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1
por: AL Assaf, Carla, et al.
Publicado: (2014)

A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia
por: Tirefort, Yordanka, et al.
Publicado: (2014)

Patient with clinical celiac disease mimicking triple‐negative essential thrombocythemia
por: Ali, Elrazi A., et al.
Publicado: (2022)

Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer
por: Rojas L, Katerin, et al.
Publicado: (2019)

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016)

Characterisation of Platelet Sensitivity in Severe COVID-19
por: Saputil, Rocel C., et al.
Publicado: (2022)

Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition
por: Beykou, Melina, et al.
Publicado: (2022)

Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time
por: Garner, S. F., et al.
Publicado: (2016)

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial
por: Gisslinger, Heinz, et al.
Publicado: (2019)

Heparanase from triple-negative breast cancer and platelets acts as an enhancer of metastasis
por: Yang, Wen-Jing, et al.
Publicado: (2020)

Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer
por: Johnstone, Cameron N., et al.
Publicado: (2018)

Lyophilised Platelet-Rich Fibrin: Physical and Biological Characterisation
por: Ngah, Nurul Aida, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s1c5580buh1gujsuncidtrhpn5